Decentralization and Collective Intelligence: Pioneering a New Era in Precision Medicine

Join us on a journey to revolutionize clinical research programs with decentralized collective intelligence. See decentralization in motion with the SOPHiA DDM™ Platform, designed to connect and integrate multimodal data from 750+ institutions across 70 countries. Learn how to unlock the platform’s potential to identify unmet needs, accelerate precision medicine development, and improve patient access to new therapies by securely sharing knowledge on a global scale. Discover how SOPHiA DDM™ continues to drive and accelerate the adoption of homologous recombination deficiency (HRD) analysis and our decentralized approach to MSK-ACCESS®.

Presented by: T. Scott Reid – VP, Global Head of Diagnostics – SOPHiA GENETICS

Disclaimer notice:

The term SOPHIA used by the speaker refers to SOPHiA GENETICS and its products.
The opinions expressed during this presentation are those of the speaker and may not represent the opinions of SOPHiA GENETICS. SOPHiA GENETICS does not provide support in the validation of custom products for clinical use. SOPHiA GENETICS products are for Research Use Only and not for use in diagnostic procedures unless specified otherwise. Information about products that may or may not be available in different countries and if applicable, may or may not have received approval or market clearance by a governmental regulatory body for different indications for use. Please contact us at[email protected] to obtain the appropriate product information for your country of residence.

Event Date
April 16, 2023 –

Event Type


Event Location

North America

Areas of Interest

BioPharma, Multimodality

pink dots icon

Want to know more?
Get in touch with us.

Our client services team is on hand to help.